Andy Scharenberg

Andy Scharenberg

Co-founder & Chief Executive Officer at Umoja Biopharma
Seattle, Washington, United States

Andy Scharenberg is Chief Executive Officer at Umoja Biopharma and Executive Partner at MPM BioImpact. He co-founded Generation Bio and Pregenen, and has served as Chief Scientific Officer at Casebia Therapeutics and Cellectis therapeutics. He has chaired scientific advisory boards at Alpine Immune Sciences and Generation Bio, and was a professor at the University of Washington and principal investigator at Seattle Children's Hospital and Research Institute.

See all 6 stories, episodes and videos about Andy Scharenberg.

Organizations

See all 10
  • Umoja Biopharma logo
    Umoja Biopharma Executive Officer, Director 2021–present, Co-founder & Chief Executive Officer 2019–present · current
  • MPM BioImpact Executive Partner 2019–present · current
  • Casebia Therapeutics Chief Scientific Officer 2017–2019 · past

Education

  • University of North Carolina School of Medicine MD, Medicine · 1991–1993

Online